We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$23.5B
AUM Growth
+$2.05B
Cap. Flow
-$1.67M
Cap. Flow %
-0.01%
Top 10 Hldgs %
21.02%
Holding
3,355
New
222
Increased
1,262
Reduced
1,627
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 10.74%
2 Financials 4.97%
3 Consumer Discretionary 4.15%
4 Healthcare 3.65%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLNE icon
3051
Clean Energy Fuels
CLNE
$384M
$84K ﹤0.01%
22,006
+8,154
+59% +$29.7K
IQ icon
3052
iQIYI
IQ
$1.28B
$84K ﹤0.01%
17,245
-18,178
-51% -$85.9K
CXH
3053
DELISTED
MFS Investment Grade Municipal Trust
CXH
$83K ﹤0.01%
10,951
+57
+0.5% +$405
EARN
3054
Ellington Residential Mortgage REIT
EARN
$163M
$83K ﹤0.01%
13,491
+13
+0.1% +$77
MOMO
3055
Hello Group
MOMO
$867M
$83K ﹤0.01%
11,883
-170
-1% -$1.18K
WULF icon
3056
TeraWulf
WULF
$8.58B
$83K ﹤0.01%
+34,425
New +$46.9K
UAMY icon
3057
United States Antimony
UAMY
$736M
$82K ﹤0.01%
329,019
+18,425
+6% +$5.52K
SUPV
3058
Grupo Supervielle
SUPV
$725M
$81K ﹤0.01%
20,000
ACHR icon
3059
Archer Aviation
ACHR
$4.84B
$79K ﹤0.01%
12,888
+1,961
+18% +$11.1K
BLNK icon
3060
Blink Charging
BLNK
$85.6M
$79K ﹤0.01%
23,361
-6,458
-22% -$20.2K
EPM icon
3061
Evolution Petroleum
EPM
$134M
$78K ﹤0.01%
13,500
CRON
3062
Cronos Group
CRON
$1.17B
$77K ﹤0.01%
36,971
-2,424
-6% -$4.71K
XERS icon
3063
Xeris Biopharma Holdings
XERS
$1.55B
$76K ﹤0.01%
32,170
-3,500
-10% -$6.46K
BBAI icon
3064
BigBear.ai
BBAI
$1.56B
$75K ﹤0.01%
35,031
+1,031
+3% +$1.67K
EVGO icon
3065
EVgo
EVGO
$497M
$75K ﹤0.01%
21,073
-9,246
-30% -$27.4K
IBRX icon
3066
ImmunityBio
IBRX
$8.2B
$75K ﹤0.01%
14,950
FCEL icon
3067
FuelCell Energy
FCEL
$1.73B
$74K ﹤0.01%
1,540
+129
+9% +$4.94K
ONL
3068
Orion Office REIT
ONL
$161M
$74K ﹤0.01%
12,899
+2,643
+26% +$13.8K
NKTR icon
3069
Nektar Therapeutics
NKTR
$2.57B
$73K ﹤0.01%
8,661
-318
-4% -$2.41K
CRDL
3070
Cardiol Therapeutics
CRDL
$175M
$72K ﹤0.01%
85,201
ME
3071
DELISTED
23andMe Holding Co
ME
$72K ﹤0.01%
3,914
-5,133
-57% -$88.8K
BDN
3072
Brandywine Realty Trust
BDN
$541M
$70K ﹤0.01%
+12,954
New +$56.8K
WEAT icon
3073
Teucrium Wheat Fund
WEAT
$298M
$70K ﹤0.01%
2,353
-1,283
-35% -$37.2K
NKLA
3074
DELISTED
Nikola Corporation Common Stock
NKLA
$70K ﹤0.01%
2,672
+582
+28% +$18.1K
DOUG icon
3075
Douglas Elliman
DOUG
$184M
$69K ﹤0.01%
23,375
-1,299
-5% -$2.72K

Similar funds

Cambridge Investment Research Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Cambridge Investment Research Advisors held 3,355 positions worth $23.5B, up 9.6% from $21.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q4 2023 filing shows 222 new, 1,262 increased, 1,627 reduced and 171 closed positions. Its largest new stake was Innovator Equity Managed Floor ETF: 254,744 shares worth $6.96M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $62.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q4 2023 buy was Innovator Equity Managed Floor ETF: 254,744 shares worth $6.96M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q4 2023, an estimated $73.8M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $62.7M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2023 Corporate Bond ETF in Q4 2023, selling an estimated $15M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $23.5B portfolio in Q4 2023.
  • Cambridge Investment Research Advisors opened 222 new positions and closed 171 in Q4 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 9.6% quarter-over-quarter to $23.5B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.